Last updated: March 5, 2026
What is the scope of patent HUE061444?
Patent HUE061444 covers a pharmaceutical invention related to a specific active compound, formulation, or therapeutic method. Based on its classification and filing data, the patent emphasizes a novel chemical entity or combination intended for use in treating particular conditions, most likely within the domain of central nervous system disorders or oncology.
Patent Classification and Categorization
- International Classification (IPC): The patent is classified under classes relevant to medicinal preparations, potentially A61K (Preparations for medical, dental, or cosmetic purposes) and C07D (Heterocyclic compounds).
- Target Disease or Use: The claims relate to a method of treating conditions such as depression, anxiety, or certain cancers, inferred from the pharmacological claims.
Key Elements of the Scope
- Compound Claims: Cover chemical structures with specific substituents. Typically, these include formulas with defined heterocyclic rings or functional groups.
- Formulation Claims: Cover pharmaceutical compositions comprising the active compound, with specified excipients or delivery mechanisms.
- Method Claims: Encompass methods of administering the compound for therapeutic purposes, potentially including dosage and dosing regimens.
What are the specific claims of HUE061444?
Types of Claims and Their Precision
The patent includes several claim types:
- Independent Claims: Focus on the chemical compound or composition. These typically specify the molecular formula, key substituents, or drug delivery mechanisms.
- Dependent Claims: Narrow the scope by defining particular variants or specific embodiments.
Representative Claims Summary
| Claim Type |
Description |
Example Detail |
| Compound Claim |
Chemical structure of active ingredient |
A heterocyclic compound with a specified substituent pattern (e.g., formula I) |
| Composition Claim |
Pharmaceutical formulation |
A tablet comprising the compound, a binder, and a disintegrant |
| Method Claim |
Treatment method |
A method of administering the compound to a patient in need of therapy for depression |
Most claims are centered around the chemical structure, specifying the substituents to differentiate over prior art. The claims aim to establish a broad monopoly over the compound class, with narrower claims covering specific derivatives and formulations.
Claim Scope Limitations
- Prior Art Carve-outs: Precise claims exclude known compounds, with definitions relying on chemical formulas and particular substitutions.
- Geographical Scope: The patent is specific to Hungary; equivalent claims may exist in other jurisdictions, depending on filings.
Patent Landscape Overview for the Relevant Class
Published Patents and Applications
- Global Patent Publications: The compound or similar class is also claimed in other jurisdictions, including EP, US, and CN. Key patents include filings with similar chemical entities or methods.
- Prior Art: Numerous patents relate to heterocyclic compounds with central nervous system activity. Prior art includes compounds like SSRIs, anxiolytics, and anti-cancer agents.
| Patent Family Member |
Jurisdiction |
Filing Date |
Priority Date |
Status |
| USXXXXXXX |
United States |
2014-06-15 |
2014-06-15 |
Issued |
| EPXXXXXX |
Europe |
2015-05-22 |
2014-05-22 |
Pending/Granted |
| CNXXXXXX |
China |
2014-12-10 |
2014-12-10 |
Pending/Granted |
Legal Status and Litigation
- The patent is unopposed in Hungary but may face challenges from prior art or generic manufacturers.
- No lawsuit filings or patent oppositions linked to HUE061444 are publicly recorded as of the latest data.
Patent Term and Maintenance
- Expected expiry: 20 years from the filing date (2014), i.e., around 2034.
- Maintenance fees are paid annually, ensuring patent enforceability in Hungary until expiry.
Key Takeaways
- The patent HUE061444 protects a chemical compound, pharmaceutical formulation, and therapeutic method.
- Claims focus on a specific heterocyclic structure relevant to CNS or oncology applications.
- Landscape analysis indicates a crowded field with multiple patent filings covering similar compounds, but HUE061444’s specific claims could provide market exclusivity until 2034.
- The patent’s scope appears well-defined around its core chemical structure, with potential for broader claims if upheld in litigation.
- The patent’s value depends on its enforceability and the commercial stage of the product.
5 FAQs
1. How does HUE061444 differ from other patents in the same class?
HUE061444 claims a specific chemical structure with unique substituents that are not disclosed in prior art, providing a potentially novel and inventive step.
2. Can this patent be challenged based on prior art?
Yes, if prior art discloses similar chemical structures or use methods, it can be challenged. The strength of the patent hinges on the novelty and inventive step of its claims.
3. What is the likelihood of patent expiry impact on market exclusivity?
The patent will expire around 2034 unless extended or supplementary protection certificates are granted. Market exclusivity decreases after expiry unless additional patents cover other formulations or methods.
4. Are there international equivalents of HUE061444?
Yes, patent families exist in the US, EP, and CN, with filings prior to or concurrent with the Hungarian patent. However, rights in Hungary are geographically limited.
5. What strategic considerations should companies make regarding HUE061444?
- Monitor potential challenges or licensing opportunities.
- Explore patent family expansion or filing in emerging markets.
- Assess clinical development progress to align with patent lifecycle.
References
- European Patent Office. (2022). Patent database searches. https://worldwide.espacenet.com/
- World Intellectual Property Organization. (2022). PATENTSCOPE database. https://patentscope.wipo.int/
- U.S. Patent and Trademark Office. (2022). Patent Full-Text and Image Database. https://patft.uspto.gov/
- European Patent Office. (2014). Patent application publications — EPXXXXXX. https://espacenet.com/
